Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 715 citing articles:

Seronegative autoimmune diseases: A challenging diagnosis
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 9, pp. 103143-103143
Closed Access | Times Cited: 68
Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
Cumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
Hepatology (2021) Vol. 73, Iss. 6, pp. 2099-2109
Open Access | Times Cited: 67
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, et al.
Hepatology International (2021) Vol. 15, Iss. 2, pp. 223-257
Open Access | Times Cited: 57
The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective
Li Wang, Zheng-Min Cao, Lili Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature
Kenneth W. Chow, Nguyen V. Pham, Britney M. Ibrahim, et al.
Digestive Diseases and Sciences (2022) Vol. 67, Iss. 9, pp. 4574-4580
Open Access | Times Cited: 52
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis
Claire Harrington, Swathi Krishnan, Cara L. Mack, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1862-1879
Open Access | Times Cited: 38
Global incidence and prevalence of autoimmune hepatitis, 1970–2022: a systematic review and meta-analysis
Jong Woo Hahn, Hye Ran Yang, James Moon, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102280-102280
Open Access | Times Cited: 36
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Álvaro Díaz‐González, Manuel Hernández‐Guerra, Indhira Pérez‐Medrano, et al.
Hepatology (2023) Vol. 77, Iss. 4, pp. 1095-1105
Open Access | Times Cited: 33
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
Francesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 53-61
Closed Access | Times Cited: 28
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
Dong‐Sik Kim, Young‐In Yoon, Beom Kyung Kim, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 299-383
Open Access | Times Cited: 15
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
Arianna Ferro, Gabriele Saccu, Simone Mattivi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 277-277
Open Access | Times Cited: 14
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study
Christina Plagiannakos, Gideon M. Hirschfield, Ellina Lytvyak, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 227-237
Open Access | Times Cited: 11
Imaging-based non-invasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline
Andrés Duarte‐Rojo, Bachir Taouli, Daniel H. Leung, et al.
Hepatology (2024)
Open Access | Times Cited: 10
Clinical and laboratory characteristics of Sjögren’s syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study
Pengfei Liang, Yanli Huang, Ziwei Hu, et al.
Clinical Rheumatology (2025)
Closed Access | Times Cited: 1
The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants
Francesca Bolis, Giorgio Cazzaniga, Fabio Pagni, et al.
Gastroenterología y Hepatología (English Edition) (2025) Vol. 48, Iss. 2, pp. 502225-502225
Open Access | Times Cited: 1
What is the optimal first-line treatment of autoimmune hepatitis? A systematic review with meta-analysis of randomised trials and comparative cohort studies
Dermot Gleeson, Marrissa Martyn-StJames, Ye Htun Oo, et al.
BMJ Open Gastroenterology (2025) Vol. 12, Iss. 1, pp. e001549-e001549
Open Access | Times Cited: 1
Auto-immune hepatitis following COVID vaccination
Mohamed Rela, Dinesh Jothimani, Mukul Vij, et al.
Journal of Autoimmunity (2021) Vol. 123, pp. 102688-102688
Closed Access | Times Cited: 51
Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani
Clinical Reviews in Allergy & Immunology (2021) Vol. 63, Iss. 2, pp. 124-137
Open Access | Times Cited: 47
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management
Eric J. Zhao, Catherine V Cheng, André Mattman, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 5, pp. e365-e375
Closed Access | Times Cited: 46
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation
Aldo J. Montaño‐Loza, Vincenzo Ronca, Maryam Ebadi, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 84-97
Open Access | Times Cited: 37
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes
Cristina C. Clement, Jaspreet Osan, Aitziber Buqué, et al.
Science Immunology (2022) Vol. 7, Iss. 74
Open Access | Times Cited: 37
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts
Timur Liwinski, Melina Heinemann, Christoph Schramm
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 485-507
Open Access | Times Cited: 35
Drug-induced autoimmune hepatitis: A minireview
Chin Kimg Tan, Danielle Ho, Lai Mun Wang, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 24, pp. 2654-2666
Open Access | Times Cited: 32
Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports
Einar S. Björnsson, Inmaculada Medina‐Cáliz, Raúl J. Andrade, et al.
Hepatology Communications (2022) Vol. 6, Iss. 8, pp. 1895-1909
Open Access | Times Cited: 29
Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood
Giuseppe Maggiore, Olivier Bernard, Antonella Mosca, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 979-988
Closed Access | Times Cited: 22

Scroll to top